REGENXBIO Inc.
RGNX
$7.77
$0.010.13%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -193.88M | -177.92M | -175.57M | -157.69M | -227.10M |
| Total Depreciation and Amortization | 15.62M | 15.77M | 15.84M | 15.99M | 16.22M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 42.52M | 33.61M | 30.17M | 27.56M | 32.23M |
| Change in Net Operating Assets | 11.78M | 25.24M | 41.68M | 30.10M | 5.53M |
| Cash from Operations | -123.96M | -103.30M | -87.89M | -84.04M | -173.13M |
| Capital Expenditure | -2.41M | -2.99M | -2.82M | -2.90M | -2.44M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -13.45M | -10.15M | -2.34M | 137.91M | 105.88M |
| Cash from Investing | -15.87M | -13.13M | -5.16M | 135.01M | 103.45M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.37M | 1.31M | 1.47M | 1.39M | 133.83M |
| Repurchase of Common Stock | -633.00K | -633.00K | -510.00K | -567.00K | -967.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 116.04M | 117.93M | 113.89M | -34.66M | -40.18M |
| Cash from Financing | 116.77M | 118.62M | 114.84M | -33.84M | 92.68M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -23.06M | 2.19M | 21.79M | 17.13M | 23.00M |